Pharma News, 2020

Pfizer’s investigational gene therapy for Duchenne muscular dystrophy (DMD) has been granted a fast track designation from the US Food and Drug Administration (FDA).

Scientists at Scripps Research have comprehensively mapped how a key class of proteins within cells regulates signals coming in from cell surface receptors.

WASHINGTON (Reuters) - The U.

ZURICH (Reuters) - Switzerland’s Relief Therapeutics and U.

Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that blocking the construction of nuclear pores complexes—large channels that control the flow of materials in and out of ...

India's Panacea Biotec has had a long history of run-ins with global regulators in the past, including being stripped of its prequalified vaccine status nearly a decade ago.

Even for people with a gene mutation tied to Parkinson's disease, coffee consumption may be associated with a lower risk of actually developing the disease, according to a new study published in t...

Pfizer has engineered a wide-ranging China pact with CStone, with an initial $200 million investment and a license to the late-stage PD-L1 drug to get things started.

GlaxoSmithKline's immunology leader Nucala has been locked in a yearslong struggle with AstraZeneca's Fasenra for dominance in rare eosinophilic asthma.

A newly identified genetic factor allows adult skin to repair itself like the skin of a newborn babe.

More than 60 million people in India—10 times the official figure—could have contracted the novel coronavirus, the country's lead pandemic agency said Tuesday, citing a nationwide study measur...

(Reuters) - Regeneron Pharmaceuticals Inc on Tuesday said its experimental two-antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients, enhancing its...